When does nurtec go generic?

Question

Accepted Answer

I’m not aware of a firm, FDA‑approved generic launch date for Nurtec ODT (ubrogepant) at this time. Here’s the current landscape:

What’s the status?	What it means for you
Brand name only – Nurtec ODT is still sold only under its brand name by the original manufacturer (Roche).	You’ll need to keep paying the brand‑name price until a generic is cleared.
Generic application pending – At least one generic applicant has filed a  ANDA (Abbreviated New Drug Application) with the FDA, but no approval has been granted yet.	The FDA’s review process typically takes 6–12 months for a single generic, but this can vary depending on the applicant’s file, any data disputes, and the FDA’s backlog.
Estimated time horizon – Most experts (including the FDA’s own projections) expect the first generic to get approved somewhere in 2025–early 2026.	This is an estimate, not a guaranteed date.
Pricing implications	Once the FDA approves a generic, the price usually drops significantly (often 30–70 % lower than the brand).

Patent landscape – The original drug is protected by a combination of patents (active ingredient, formulation, delivery system, etc.). Generic manufacturers must wait until those patents expire or get a “patent interference” decision.
Regulatory review – Even after the patents clear, the FDA still has to review the generic’s bioequivalence data, labeling, and manufacturing controls. If the FDA finds a problem, they can issue a “priority review” or “accelerated approval,” but that’s not always the case.
Market strategy – Sometimes the original manufacturer negotiates a “patent settlement” that delays generic entry to protect its market share.

Action	Why it matters
Ask your prescriber	They may know of any upcoming generic plans or alternative drugs that provide similar relief at lower cost.
Check the FDA’s website	The FDA posts generic drug approvals in real‑time; you can search for “ubrogepant” to see the latest status.
Look at pharmacy price comparison tools	Even before a generic lands, some pharmacies may offer discount programs or mail‑order options that reduce cost.
Consider therapeutic alternatives	If your migraine treatment plan is flexible, discuss other triptan or CGRP‑modulator options that may already be generic.

No official generic launch date for Nurtec yet.
The FDA likely will approve a generic sometime in 2025–2026, but it’s still a projection.
Keep an eye on the FDA announcements and talk with your provider about alternatives or cost‑saving options.

If you’d like, I can set up a quick reminder or give you links to the FDA’s generic drug database. Just let me know!

Ask Questions, Get Industry Insights … Instantly